Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Esophagus : Official Journal of the Japan Esophageal Society|July 1, 2026
Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A)Ryosuke Kita, Ryunosuke Machida, Haruhiko Fukuda, et al.
Cancer Science|May 8, 2013
Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapyYosuke Makuuchi, Kazufumi Honda, Yoshiaki Osaka, et al.
Future Oncology (London, England)|September 27, 2024
Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502Shun Yamamoto, Ken Kato, Hiroyuki Daiko, et al.
The Lancet. Gastroenterology & Hepatology|October 16, 2025
Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialHiroya Takeuchi, Ryunosuke Machida, Masahiko Ando, et al.
Psychiatry and Clinical Neurosciences|August 6, 2025
Metabolome Profiling of Yokukansan in Preventing Postoperative Delirium in Elderly Cancer Patients: A Reverse Translational StudyRyoichi Sadahiro, Katsuya Ohbuchi, Taiki Nakaya, et al.
Annals of Surgery|March 6, 2026
Prognostic Impact of Postoperative Complications After Neoadjuvant Therapy Followed by Esophagectomy for Esophageal Cancer: An Exploratory Analysis of Phase III Trial JCOG1109Eisuke Booka, Ken Kato, Yoshinori Ito, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 13, 2026
Squamous cell carcinoma antigen and carcinoembryonic antigen monitoring during post-definitive chemoradiotherapy surveillance for esophageal squamous cell carcinoma: JCOG2106AKatsuyuki Sakanaka, Ken Kato, Ryunosuke Machida, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 7, 2026
Clinical diagnostic accuracy and lymph node metastasis patterns in clinical T1bN0M0 esophageal squamous cell carcinoma: a supplementary analysis of JCOG1409Motoo Nomura, Hiroya Takeuchi, Masahiko Ando, et al.
Lancet (London, England)|June 14, 2024
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trialKen Kato, Ryunosuke Machida, Yoshinori Ito, et al.
Annals of Surgical Oncology|October 7, 2024
Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109Satoru Matsuda, Hiroya Takeuchi, Ken Kato, et al.
Pageof 22